SHL Holdings Ltd.

SHL Holdings Ltd.

SYCRF
SHL Holdings Ltd.US flagOther OTC
0.03
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
David Michael Grande
Sector
Financial Services
Industry
Insurance - Specialty
Address
Victoria Place Hamilton Bermuda HM 10
IPO Date
Aug 2, 2006
Business
SHL Holdings Ltd. (SYCRF) operates as a Bermuda-based holding company with no significant ongoing business activities; it previously provided financial guarantee insurance, reinsurance, and credit enhancement services for debt issuers worldwide through subsidiaries such as Syncora Guarantee Inc.. The company, founded in 2006 and headquartered in Hamilton, Bermuda, formerly operated as Syncora Holdings Ltd. prior to its name change in December 2020; it maintains a minimal workforce of approximately 65 employees and focuses on liquidation proceedings, including asset sales such as its real estate holdings in Detroit, Michigan in February 2022.. Recent developments center on the ongoing wind-down process with no major new partnerships, acquisitions, funding, or product launches reported in the last 1-2 years; historical activities included financial restructuring transactions completed in 2016..

Company News

APIChatGPT
  • Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions

  • Homeland Nickel Provides Corporate Update

  • SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

  • Siemens Healthineers (SHL) 2024 Product Pipeline Analysis and Ongoing Clinical Trails Insights

  • SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test

  • SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch

  • SHL Holdings Ltd. Announces Sale of Equity Investment and Subsequent Distribution

  • SHL Holdings Ltd. Addresses Recent Stock Trading and Price Activity